A Blood-Based, Multigenomic Signature is an Effective Diagnostic and Has Clinical Utility in NETs Management
The 51-gene expression-based liquid biopsy accurately diagnoses neuroendocrine tumours and is an effective surrogate marker compared to chromogranin A